US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 10.5700
  • +0.4450+4.40%
Close Apr 26 16:00 ET
  • 10.7700
  • +0.2000+1.89%
Post 16:53 ET
273.83MMarket Cap-1735P/E (TTM)

About Inovio Pharmaceuticals Company

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Company Profile

SymbolINO
Company NameInovio Pharmaceuticals
Listing DateDec 8, 1998
Founded1983
CEODr. Jacqueline E. Shea
MarketNASDAQ
Employees122
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address660 West Germantown Pike,Suite 110
CityPlymouth Meeting
ProvincePennsylvania
CountryUnited States of America
Zip Code19462-1111
Phone1-267-440-4200
Websitehttp://www.inovio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jacqueline E. Shea
  • President, Chief Executive Officer and Director
  • 2.07M
  • Peter D. Kies
  • Chief Financial Officer and Principal Accounting Officer
  • 988.73K
  • Michael John Sumner
  • Chief Medical Officer
  • --
  • Dr. Laurent Humeau, PhD
  • Chief Scientific Officer
  • 976.66K
  • Simon X. Benito
  • Chairman of the Board
  • 151.19K
  • Dr. David B. Weiner, PhD
  • Director
  • 201.79K
  • Wendy L. Yarno
  • Independent Director
  • 123.69K
  • Dr. Ann C. Miller, M.D.
  • Independent Director
  • 126.94K
  • Jay P. Shepard
  • Independent Director
  • 119.31K
  • Dr. Roger D. Dansey, M.D.
  • Independent Director
  • 108.69K
  • Lota S. Zoth, C.P.A.
  • Independent Director
  • 118.69K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg